Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Target ID: TTDR00224

Target Information
NameProliferating cell nuclear antigen    
Type of targetResearch target    
SynonymsCyclin    
PCNA    
DiseaseCardiovascular disease, unspecified    [1]
PathwayBase excision repair
Cell cycle
DNA replication
Mismatch repair
Nucleotide excision repair
UniProt IDP12004
PDB Structure1AXC; 1U76; 1U7B; 1UL1; 1VYJ; 1VYM; 1W60; 2ZVK.    
FunctionThis protein is an auxiliary protein of dna polymerase delta and is involved in the control of eukaryotic dna replication by increasing the polymerase's processibility during elongation of the leading strand.    
SequenceMFEARLVQGSILKKVLEALKDLINEACWDISSSGVNLQSMDSSHVSLVQLTLRSEGFDTY RCDRNLAMGVNLTSMSKILKCAGNEDIITLRAEDNADTLALVFEAPNQEKVSDYEMKLMD LDVEQLGIPEQEYSCVVKMPSGEFARICRDLSHIGDAVVISCAKDGVKFSASGELGNGNI KLSQTSNVDKEEEAVTIEMNEPVQLTFALRYLNFFTKATPLSSTVTLSMSADVPLVVEYK IADMGHLKYYLAPKIEDEEGS
Target ValidationClick to Find Target Validation Information.    
Inhibitor2,5-dichloro-N-p-tolylthiophene-3-sulfonamide[2]
3- ([3]
4- (7-Butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)-phenol[4]
4- (phenyldiazenyl)-1H-pyrazole-3,5-diamine[3]
4-[ (3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol[3]
6- (3-Amino-benzyloxy)-9H-purin-2-ylamine[5]
6- (3-Methyl-benzyloxy)-9H-purin-2-ylamine[5]
6- (Cyclohex-3-enylmethoxy)-9H-purin-2-ylamine[5]
6-Cyclohexylmethoxy-pyrimidine-2,4,5-triamine[6]
GW-8510[7]
MERIOLIN 1[8]
MERIOLIN 2[8]
MERIOLIN 3[8]
MERIOLIN 4[8]
MERIOLIN 5[8]
MERIOLIN 6[8]
MERIOLIN 7[8]
MERIOLIN 8[8]
NU-2058[9]
NU-6027[6]
PD-0183812[10]
PURVALANOLA[11]
RESCOVITINE[12]
SB-216763[13]
Cross References 3D Structure
Related Literature
On-Line Medical Dictionary
Ref 1Apoptosis and proliferation of cardiomyocytes in heart failure of different etiologies. Cardiovasc Pathol. 2000 May-Jun;9(3):149-52. To Reference
Ref 2Bioorg. Med. Chem. Lett. 20(13):3863-3867 (2010) To Reference
Ref 3J Med Chem. 2006 Nov 2;49(22):6500-9.4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects. To Reference
Ref 4J Med Chem. 2003 Jan 16;46(2):222-36.Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects. To Reference
Ref 5J Med Chem. 2002 Aug 1;45(16):3381-93.Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivatives. To Reference
Ref 6Bioorg Med Chem Lett. 2003 Jan 20;13(2):217-22.4-Alkoxy-2,6-diaminopyrimidine derivatives: inhibitors of cyclin dependent kinases 1 and 2. To Reference
Ref 7Bioorg Med Chem Lett. 2004 Feb 23;14(4):953-7.Discovery and in vitro evaluation of potent TrkA kinase inhibitors: oxindole and aza-oxindoles. To Reference
Ref 8J Med Chem. 2008 Feb 28;51(4):737-51. Epub 2008 Jan 31.Meriolins (3-(pyrimidin-4-yl)-7-azaindoles): synthesis, kinase inhibitory activity, cellular effects, and structure of a CDK2/cyclin A/meriolin complex. To Reference
Ref 9J Med Chem. 2004 Jul 15;47(15):3710-22.N2-substituted O6-cyclohexylmethylguanine derivatives: potent inhibitors of cyclin-dependent kinases 1 and 2. To Reference
Ref 10J Med Chem. 2000 Nov 30;43(24):4606-16.Pyrido[2,3-d]pyrimidin-7-one inhibitors of cyclin-dependent kinases. To Reference
Ref 11Biochem J. 2007 Dec 15;408(3):297-315.The selectivity of protein kinase inhibitors: a further update. To Reference
Ref 12Eur J Med Chem. 2010 Mar;45(3):1158-66. Epub 2009 Dec 21.Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors. To Reference
Ref 13J Med Chem. 2010 Feb 11;53(3):994-1003.Benzo[e]isoindole-1,3-diones as potential inhibitors of glycogen synthase kinase-3 (GSK-3). Synthesis, kinase inhibitory activity, zebrafish phenotype, and modeling of binding mode. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543